Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We report subxiphoid uniportal robotic thymectomy without intercostal access using the da Vinci Xi multi-port robot system. A 4-cm vertical incision was made 1 cm caudal to the xiphoid process. The AIRSEAL ROBOTIC SOLUTION, an air seal system compatible with the da Vinci port was used to insufflate CO2 at 8 mmHg. During port insertion, the left and right hands were crossed into the wound, with the camera, left hand, and right hand inserted in the order from the anterior chest to the dorsal side. To reduce the interference between the ports at the head, a key technique is to pull the camera port forward to prevent it from colliding with the other ports. Subxiphoid uniportal robotic thymectomy using the da Vinci Xi is a technique that combines excellent surgical visibility from the subxiphoid process, minimal invasiveness and enhanced operability provided by the robotic system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12209797PMC
http://dx.doi.org/10.1093/ejcts/ezaf127DOI Listing

Publication Analysis

Top Keywords

subxiphoid uniportal
12
uniportal robotic
12
robotic thymectomy
12
thymectomy vinci
8
robotic
5
subxiphoid
4
vinci
4
vinci system†
4
system† report
4
report subxiphoid
4

Similar Publications

Background: Video-assisted thoracoscopic surgery (VATS) is a minimally invasive technique for early thymoma, early-stage non-small cell lung cancer (NSCLC), and primary spontaneous pneumothorax (PSP). The subxiphoid uniportal VATS (SU-VATS) approach offers potential advantages over the intercostal uniportal VATS (IU-VATS) by reducing nerve injury and postoperative pain.

Methods: A single-center retrospective study at The Fifth Hospital of Ganzhou included 756 patients who underwent SU-VATS or IU-VATS between January 2018 and September 2024.

View Article and Find Full Text PDF

Background: The treatment of anterior mediastinal masses primarily utilizes video-assisted thoracoscopic surgery (VATS) thymectomy. This study introduced a subxiphoid uniportal VATS thymectomy (SUVT) using a double sternum retractor without artificial pneumothorax and compared its efficacy and safety to traditional VATS thymectomy (non-SUVT group).

Methods: Patients diagnosed with anterior mediastinal masses who underwent the VATS thymectomy in West China Hospital, Sichuan University from June 2023 to May 2024 were included.

View Article and Find Full Text PDF

We report subxiphoid uniportal robotic thymectomy without intercostal access using the da Vinci Xi multi-port robot system. A 4-cm vertical incision was made 1 cm caudal to the xiphoid process. The AIRSEAL ROBOTIC SOLUTION, an air seal system compatible with the da Vinci port was used to insufflate CO2 at 8 mmHg.

View Article and Find Full Text PDF

This study aims to compare the early outcomes of the surgeon-powered robotic uniportal subxiphoid resection technique with conventional uniportal techniques. A retrospective analysis was conducted on patients operated on for lung cancer between January 2022 and December 2023, comparing those who underwent uniportal lung resection with those who received the uniportal subxiphoid surgical technique. Out of 90 patients in the study, 31 underwent subxiphoid resection while 59 underwent the uniportal surgical technique.

View Article and Find Full Text PDF

New Trends in Uniportal Video-Assisted Thoracoscopic Surgery for Primary Spontaneous Pneumothorax: A Narrative Review.

J Clin Med

March 2025

Pneumothorax Research Center and Division of Thoracic Surgery, Nissan Tamagawa Hospital, 4-8-1 Seta Setagaya-ku, Tokyo 158-0095, Japan.

Minimally invasive thoracic surgery has advanced since the introduction of multiportal video-assisted thoracoscopic surgery (mVATS) in 1991. Primary spontaneous pneumothorax (PSP) is an ideal condition for refining minimally invasive techniques owing to its straightforward procedures and predictable bullae distributions. Uniportal VATS (uVATS), which involves a single incision, is an alternative to mVATS, offering reduced postoperative pain, lower paresthesia rates, and comparable recurrence outcomes.

View Article and Find Full Text PDF